Management of sleep disorders in females diagnosed with the polycystic ovarian syndrome: A systematic review

Paper Details

Research Paper 10/08/2024
Views (23) Download (5)
current_issue_feature_image
publication_file

Management of sleep disorders in females diagnosed with the polycystic ovarian syndrome: A systematic review

Renuka Jakhar, Elina Dewanji Sen, Preeti Rastogi
Int. J. Biosci.25( 2), 283-291, August 2024.
Certificate: IJB 2024 [Generate Certificate]

Abstract

Females diagnosed with polycystic ovarian syndrome (PCOS) are more likely to exhibit obstructive sleep apnoea (OSA), difficulty falling asleep, difficulty in maintaining sleep, poor sleep quality, daytime sleepiness and restless leg syndrome. Presence of sleep disturbances or sleep disorders results in poor day time work performance, lack of attention, memory and overall feeling of well-being. The present systematic review focus on interventions for management of sleep disorders in PCOS females. Online literature search of relevant studies across databases of PubMed, Directory of Open Access Journals (DOAJ), Google Scholar and Physiotherapy Evidence Database (PEDro) from beginning to June 2022 was performed (PROSPERO:CRD42022347538). The methodological quality of included RCT was assessed using Cochrane ROB tool and pre-post study was assessed using NIH quality assessment tool. Results of review were reported using qualitative synthesis. One RCT and one pre-post study was included and analysed in this review. Age range of participants in the study was from 18-40 years. The studies reported 8 weeks’ interventions of continuous positive airway pressure (CPAP), melatonin tablets with magnesium oxide and melatonin tablets alone. Sleep outcomes were assessed subjectively by Stanford Sleepiness Scale and Iranian version of the Pittsburg Sleep Quality Index and objectively by polysomnographic recordings. Qualitative synthesis of included studies indicated positive results of interventions on sleep outcomes in PCOS females though with limited evidence. CPAP, melatonin-magnesium co-supplementation; and melatonin alone for 8 weeks have beneficial effects on some sleep outcomes in PCOS females. Moreover, there is need to conduct more good quality research trials.

VIEWS 22

Alizadeh M, Karandish M, Asghari Jafarabadi M, Heidari L., Nikbakht R, Babaahmadi Rezaei H, Mousavi R. 2021. Metabolic and hormonal effects of melatonin and/or magnesium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Nutrition & metabolism 18, 57. https://doi.org/10.1186/s12986-021-00586-9

Bahman M, Hajimehdipoor H, Afrakhteh M, Bioos S, Hashem-Dabaghian F, Tansaz M. 2018. The importance of sleep hygiene in polycystic ovary syndrome from the view of Iranian traditional medicine and modern medicine. International Journal of Preventive Medicine 9, 87. https://doi.org/10.4103/ijpvm.IJPVM_352_16

Barber TM, Kyrou I, Randeva HS, Weickert MO. 2021. Mechanisms of insulin resistance at the crossroad of obesity with associated metabolic abnormalities and cognitive dysfunction. International Journal of Molecular Sciences 22, 546. https://doi.org/10.3390/ijms22020546

Broughton R. 1982. Performance and evoked potential measures of various states of daytime sleepiness. Sleep 5(Suppl 2), S135–S146. https://doi.org/10.1093/sleep/5.s2.s135

Bui LM, Bazalakova M, Antony KM, Cooney LG. 2022. Obstructive sleep apnea: another condition to screen for in women with infertility. Women 2, 56-63. https://doi.org/10.3390/women2010006

Caltekin MD, Hamamci M, Onat T, Kirmizi DA, Baser E, Yalvac ES. 2021. Evaluation of sleep quality, restless legs syndrome, anxiety, and depression in polycystic ovary syndrome. Journal of Turkish Sleep Medicine 8, 243-249. https://doi.org/10.4274/jtsm.galenos.2021.85057

Connor J, Norton R, Ameratunga S, Robinson E, Civil I, Dunn R, Bailey J, Jackson R. 2002. Driver sleepiness and risk of serious injury to car occupants: population-based case-control study. British Medical Journal 324, 1125. https://doi.org/10.1136/bmj.324.7346.1125

Dennett CC, Simon J. 2015. The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment. Diabetes Spectrum 28, 116-120. https://doi.org/10.2337/diaspect.28.2.116

Fernandez RC, Moore VM, Van Ryswyk EM, Varcoe TJ, Rodgers RJ, March WA, Moran LJ, Avery JC, McEvoy RD, Davies MJ. 2018. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nature and Science of Sleep 10, 45-64. https://doi.org/10.2147/NSS.S127475

Hung JH, Hu LY, Tsai SJ, Yang AC, Huang MW, Chen PM, Wang SL, Lu T, Shen CC. 2014. Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study. PLoS One 9, e97041. https://doi.org/10.1371/journal.pone.0097041

Jakhar R, Sen ED, Dutt R. 2022. Awareness of polycystic ovarian syndrome among college-going females in Gurgaon: a cross-sectional study. Annals of the National Academy of Medical Sciences (India) 58, 149–156. https://doi.org/10.1055/s-0042-1750359

Kahal H, Kyrou I, Uthman OA, Brown A, Johnson S, Wall PDH, Metcalfe A, Parr DG, Tahrani AA, Randeva HS. 2020. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath 24, 339-350. https://doi.org/10.1007/s11325-019-01835-1

Kahal H, Tahrani AA, Kyrou I, Dimitriadis GK, Kimani PK, Barber TM, Nicholls M, Ali A, Weickert MO, Randeva HS. 2020. The relationship between obstructive sleep apnoea and quality of life in women with polycystic ovary syndrome: a cross-sectional study. Therapeutic Advances in Endocrinology and Metabolism 11, 2042018820906689. https://doi.org/10.1177/2042018820906689

Khosravi A, Emamian MH, Hashemi H, Fotouhi A. 2021. Components of Pittsburgh Sleep Quality Index in Iranian adult population: an item response theory model. Sleep Medicine: X 3, 100038. https://doi.org/10.1016/j.sleepx.2021.100038

Lim AJ, Huang Z, Chua SE, Kramer MS, Yong EL. 2016. Sleep duration, exercise, shift work and polycystic ovarian syndrome-related outcomes in a healthy population: a cross-sectional study. PLoS One 11, e0167048. https://doi.org/10.1371/journal.pone.0167048

Martins FO, Conde SV. 2021. Gender differences in the context of obstructive sleep apnea and metabolic diseases. Frontiers in Physiology 12, 792633. https://doi.org/10.3389/fphys.2021.792633

Mehra R, Kashyap SR, Shah V. 2020. Is better sleep beneficial for metabolic outcomes in obese female adolescents with polycystic ovarian syndrome? The Journal of Clinical Endocrinology and Metabolism 105, e1910-2.

Naz MSG, Tehrani FR, Ozgoli G. 2019. Polycystic ovary syndrome in adolescents: a qualitative study. Psychology Research and Behavior Management 12, 715-723. https://doi.org/10.2147/PRBM.S207727

Pramodh S. 2020. Exploration of lifestyle choices, reproductive health knowledge, and polycystic ovary syndrome (PCOS) awareness among female Emirati university students. International Journal of Women’s Health 12, 927-938. https://doi.org/10.2147/IJWH.S272867

Rao P, Bhide P. 2020. Controversies in the diagnosis of polycystic ovary syndrome. Therapeutic Advances in Reproductive Health 14, 1-11. https://doi.org/10.1177/2633494120913032

Tasali E, Chapotot F, Leproult R, Whitmore H, Ehrmann DA. 2011. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism 96, 365–374. https://doi.org/10.1210/jc.2010-1187

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ, International PCOS Network. 2018. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertility and Sterility 110, 364-379. https://doi.org/10.1016/j.fertnstert.2018.05.004

Tseng PH, Chiu HM, Tu CH, Wu MS, Ho HN, Chen MJ. 2021. Obesity exacerbates irritable bowel syndrome-related sleep and psychiatric disorders in women with polycystic ovary syndrome. Frontiers in Endocrinology (Lausanne) 12, 779456. https://doi.org/10.3389/fendo.2021.779456

Wolf WM, Wattick RA, Kinkade ON, Olfert MD. 2018. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. International Journal of Environmental Research and Public Health 15, 2589. https://doi.org/10.3390/ijerph15112589